HCV synthesis project: preliminary analyses of HCV prevalence in relation to age and duration of injection.
about
Hepatitis C Infection Among Injecting Drug Users in England and Wales (1992-2006): There and Back Again?HCV and HIV infection among heroin addicts in methadone maintenance treatment (MMT) and not in MMT in Changsha and Wuhan, ChinaAgent-Based Model Forecasts Aging of the Population of People Who Inject Drugs in Metropolitan Chicago and Changing Prevalence of Hepatitis C InfectionsPositive deviance control-case life history: a method to develop grounded hypotheses about successful long-term avoidance of infection.The HCV Synthesis Project: scope, methodology, and preliminary results.Gender-specific situational correlates of syringe sharing during a single injection episode.Injection drug use among street-involved youth in a Canadian setting.Strategies to avoid opiate withdrawal: implications for HCV and HIV risksPrevalence and incidence of HCV infection among Vietnam heroin users with recent onset of injection.Potential impact of vaccination on the hepatitis C virus epidemic in injection drug users.Prevalence and correlates of Hepatitis C among injection drug users: The significance of duration of use, incarceration and race/ethnicity.Prescription opioid misuse and its relation to injection drug use and hepatitis C virus infection: protocol for a systematic review and meta-analysis.Gender influences on hepatitis C incidence among street youth in a Canadian setting.Associations between prescription opioid injection and Hepatitis C virus among young injection drug users.High regional variability of HIV, HCV and injecting risks among people who inject drugs in Poland: comparing a cross-sectional bio-behavioural study with case-based surveillanceHepatitis C Virus Disease Progression in People Who Inject Drugs: Protocol for a Systematic Review and Meta-Analysis.How can hepatitis C be prevented in the long term?Hepatitis C treatment eligibility and comorbid medical illness in methadone maintenance (MMT) and non-MMT patients: a case-control studyThe role of social networks and geography on risky injection behaviors of young persons who inject drugs.Prevalence and correlates of former injection drug use among young noninjecting heroin users in Chicago.Injecting risk behavior among traveling young injection drug users: travel partner and city characteristics.HCV infection prevalence lower than expected among 18-40-year-old injection drug users in San Diego, CA.Transmission of hepatitis C virus infection among younger and older people who inject drugs in Vancouver, Canada.A meta-analysis of the hepatitis C virus distribution in diverse racial/ethnic drug injector groupsPrevalence of HIV infection and risk behaviors among younger and older injecting drug users in the United States, 2009The HCV care continuum among people who use drugs: protocol for a systematic review and meta-analysisMeta-regression of hepatitis C virus infection in relation to time since onset of illicit drug injection: the influence of time and place.Can intranasal drug use reduce HCV infection among injecting drug users?The lived experience of hepatitis C and its treatment among injecting drug users: qualitative synthesis.Transitions from injecting to non-injecting drug use: potential protection against HCV infection.Higher incidence of HCV in females compared to males who inject drugs: A systematic review and meta-analysis.Methadone maintenance patients' knowledge, attitudes, beliefs, and experiences concerning treatment for hepatitis C virus infection.Gender, Transience, Network Partnerships and Risky Sexual Practices Among Young Persons who Inject Drugs.The impact of needle and syringe provision and opiate substitution therapy on the incidence of hepatitis C virus in injecting drug users: pooling of UK evidence.Older injectors: an emerging and under-recognised public health issue.The effects of widespread methadone treatment on the molecular epidemiology of hepatitis C virus infection among injection drug users in Hong Kong.Gender differences in hepatitis C seroprevalence and suboptimal vaccination and hepatology services uptake amongst substance misusers.The increasing mortality burden of liver disease among opioid-dependent people: cohort study.Risk factors for HCV infection among young adults in rural New York who inject prescription opioid analgesics.A randomized trial of a hepatitis care coordination model in methadone maintenance treatment.
P2860
Q27488973-995C8B76-4123-49B9-8884-E9C4BB36EC7FQ28483942-4CF7B8FF-D9C9-4448-AD1D-C7F2EB453AFFQ28548643-304D48BF-F5F4-49E6-A69C-D0CB29D41066Q30842338-7A30DC87-825A-4BCB-B639-9932C4B8AC9DQ33369233-50599155-313F-4DC6-BBD8-B3B995E483B0Q33410148-3A981BCD-2986-40F8-A11F-3DA6FE821122Q33459548-F3F0B08F-780A-4EE4-ADE0-6E019EE4FB1FQ33507211-2CB25444-5BAB-41BD-8359-CE5BB21672B0Q33754364-62FC92CC-FF42-4458-80C3-D249CCED6C28Q33824723-E803D988-F14F-4D3F-8660-CDABD48EABDDQ33840231-05E3DEFA-57EA-4161-B783-015F351459FDQ34153684-2301D477-5D30-4AE8-BF75-28EE7B333ED0Q34622596-DDB3843B-68CC-42DD-A524-E4B58B46AC9AQ34971493-4A6DC248-0AC9-4131-8BA6-38171DF8D11DQ35120376-37E27132-BB9B-42FA-8AA5-95B944298228Q35922263-05FED255-CF88-41A1-A742-60206C81B489Q36226863-0D5E6C08-F966-481E-89DA-BE11545C2DA9Q36296251-5D43FBD0-C46A-40D5-8C53-2CD37DDA1356Q36701887-F89E0490-4728-42C9-B2F4-E205D2BC4AD2Q36784841-9A1C7784-7F55-41F0-BB21-D2DF24DEB477Q36882030-825425D8-C19A-4655-BC1E-7AFEDE85E7B6Q36882069-F1999B1C-645E-4D71-8D84-ED4874EECF01Q36922133-FEC7ED56-0C4B-424B-9B9A-6335CB164D89Q37031381-23BDBAF8-69CC-4BCB-8DBD-B0F0399D6C94Q37040594-F3575635-F508-4042-BB46-AFAB02CFF27DQ37084628-FEAF8885-F2F4-42FD-BEE0-310F6A94FB37Q37306146-FCDBB38D-BDBC-47C9-9456-A7ED94D062C2Q37505027-1A3C6545-9BE7-4631-BCAF-FC40FCE314B3Q37582072-7000C6E4-8365-4AE3-BE54-2B54A3807890Q37625564-2049A2CF-942C-43EF-BE58-6F915E4EFF09Q38993437-1BC9D8EC-A7AD-4160-93C9-466D017A2279Q39918668-FFC58849-3D06-4B83-95D3-A6506FA36622Q40537570-D9FFD7FC-D268-4613-A527-5EFDDC32B2F3Q42602432-CF25B433-58C7-471E-B57F-0F8F96B4393FQ43011090-D69A4654-3133-4620-AD2C-8626AEADD7CDQ43036763-57AC973A-75C3-4050-B9C5-F9F2176E2C25Q43741838-DB6C9A81-CD9D-4924-B936-8383445F794DQ44351562-F9317F0F-8491-4919-977B-F010F53F9262Q51816433-C6B068CC-1B95-4959-9E39-B083E696F981Q51867806-70AFAE0D-FFD6-41FA-A8F2-DBCFB05E54A3
P2860
HCV synthesis project: preliminary analyses of HCV prevalence in relation to age and duration of injection.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
HCV synthesis project: prelimi ...... age and duration of injection.
@en
type
label
HCV synthesis project: prelimi ...... age and duration of injection.
@en
prefLabel
HCV synthesis project: prelimi ...... age and duration of injection.
@en
P2093
P1476
HCV synthesis project: prelimi ...... age and duration of injection.
@en
P2093
Corina Lelutiu-Weinberger
Don C Des Jarlais
Peter L Flom
Rebecca Stern
Roberta Scheinmann
Shiela Strauss
P304
P356
10.1016/J.DRUGPO.2007.01.016
P50
P577
2007-05-02T00:00:00Z